Cryptocurrencies
Iovance Biotherapeutics To Present At The 40th Annual J.P. Morgan Healthcare Conference On January 12, 2022
SAN CARLOS, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that Fred Vogt, PhD, Esq., Interim Chief Executive Officer, Read more…